Increase/Decrease in Cash: The total change in cash for the company over the given period.
aTyr Pharma, Inc. (ATYR) had Increase/Decrease in Cash of $-1.03M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$0.19M |
|
$-74.12M |
|
-- |
|
$0.19M |
|
$77.82M |
|
$-77.63M |
|
$3.50M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-74.12M |
|
$-77.63M |
|
$-77.93M |
|
92.99M |
|
92.99M |
|
$-0.80 |
|
$-0.80 |
|
| Balance Sheet Financials | |
$80.24M |
|
$4.26M |
|
$12.77M |
|
$93.00M |
|
$15.15M |
|
$0.26M |
|
$10.57M |
|
$25.71M |
|
$67.29M |
|
$67.29M |
|
$67.29M |
|
98.03M |
|
| Cash Flow Statement Financials | |
$-61.99M |
|
$-5.05M |
|
$66.01M |
|
$14.01M |
|
$12.98M |
|
|
Increase/Decrease in Cash |
$-1.03M |
$5.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
5.30 |
|
-- |
|
-- |
|
0.00 |
|
0.01 |
|
100.00% |
|
-40856.32% |
|
-40856.32% |
|
-41014.74% |
|
-39012.11% |
|
-39009.47% |
|
$-62.05M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.22 |
|
1677.08 |
|
-110.16% |
|
-110.16% |
|
-79.70% |
|
-109.74% |
|
$0.69 |
|
$-0.67 |
|
$-0.67 |
|